Novoxel Reaffirms Tixel's Commitment to Safe Treatment Technology Amid FDA Warnings
In light of the U.S. Food and Drug Administration's (FDA) recent alert concerning the safety of radiofrequency (RF) microneedling devices, Novoxel, renowned for its innovative Tixel technology, has taken the opportunity to reassure both practitioners and patients of its superior safety standards.
Tixel employs a groundbreaking approach called Thermo-Mechanical Action (TMA), which sets it apart from traditional RF and other mechanisms commonly utilized in dermatological procedures. Unlike RF devices that penetrate the skin, Tixel uses carefully controlled heat to activate a natural rejuvenation process in the skin, minimizing risks associated with invasiveness.
Dr. Ifat Klein, the Vice President of Clinical Affairs at Novoxel, emphasizes the significance of using technologies with established safety profiles. "Tixel's unique technology has a safety profile that is industry-leading, reinforcing the importance of opting for devices backed by substantial clinical evidence," she states.
The precision of Tixel's operation is noteworthy. The delivery of thermal energy is meticulously confined to the epidermis and upper dermis layers, effectively reducing the likelihood of complications such as scarring or subcutaneous fat loss. The device's capacity to provide effective results without penetrating the skin distinguishes it from needle-based treatment options.
Dr. Amy B. Lewis, a dermatologist at Lewis Dermatology Associates, highlights Tixel’s advantages: "It's a technology we trust daily to deliver visible improvements safely and without the worry of complications. The ease of use and reproducible results make it ideal for both my trained staff and me."
With a proven track record spanning over a decade and hundreds of thousands of treatments administered globally, Tixel boasts an impressive safety statistic: 99.99% of treatments result in safe outcomes, without reports of burns, scarring, or fat loss. This remarkable level of safety has cultivated trust among practitioners and patients alike, ensuring Tixel's place in dermatological practices across various skin types and demographics.
Furthermore, Tixel’s efficacy has been solidified through an extensive body of research. More than 30 peer-reviewed clinical studies conducted on over 800 patients demonstrate consistent and reliable results, contributing to high satisfaction rates among users. The Tixel devices carry FDA clearance, validating their safety and effectiveness within the regulatory framework.
Dr. Karen Herman, a dermatologist at Rejuvené MD, affirms that Tixel plays an integral role in her practice: "Our team and patients trust it. It's safe year-round for every skin type and delivers visible results without needles or lasers — giving patients comfort, confidence, and natural-looking outcomes."
In addition to its commitment to safety, Novoxel's unique technology represents the forefront of the next-generation energy-based devices designed for skin treatment. Operating since 2011, Novoxel has established itself as a leader in Thermo-Mechanical Action technology, which delivers pure thermal energy to the skin without invasive procedures.
With established markets in the USA, Canada, Europe, and beyond, Tixel is set to redefine how non-invasive treatments are approached, emphasizing minimal downtime while providing significant clinical outcomes in skin rejuvenation and other applications worldwide. For those seeking a notable advance in dermatological technology, Tixel remains a trusted choice supported by substantial clinical validation and a deep commitment to patient safety.
For more detailed information regarding Tixel and the Thermo-Mechanical Action technology, visit www.novoxel.com or contact [email protected].
Tixel employs a groundbreaking approach called Thermo-Mechanical Action (TMA), which sets it apart from traditional RF and other mechanisms commonly utilized in dermatological procedures. Unlike RF devices that penetrate the skin, Tixel uses carefully controlled heat to activate a natural rejuvenation process in the skin, minimizing risks associated with invasiveness.
Dr. Ifat Klein, the Vice President of Clinical Affairs at Novoxel, emphasizes the significance of using technologies with established safety profiles. "Tixel's unique technology has a safety profile that is industry-leading, reinforcing the importance of opting for devices backed by substantial clinical evidence," she states.
The precision of Tixel's operation is noteworthy. The delivery of thermal energy is meticulously confined to the epidermis and upper dermis layers, effectively reducing the likelihood of complications such as scarring or subcutaneous fat loss. The device's capacity to provide effective results without penetrating the skin distinguishes it from needle-based treatment options.
Dr. Amy B. Lewis, a dermatologist at Lewis Dermatology Associates, highlights Tixel’s advantages: "It's a technology we trust daily to deliver visible improvements safely and without the worry of complications. The ease of use and reproducible results make it ideal for both my trained staff and me."
With a proven track record spanning over a decade and hundreds of thousands of treatments administered globally, Tixel boasts an impressive safety statistic: 99.99% of treatments result in safe outcomes, without reports of burns, scarring, or fat loss. This remarkable level of safety has cultivated trust among practitioners and patients alike, ensuring Tixel's place in dermatological practices across various skin types and demographics.
Furthermore, Tixel’s efficacy has been solidified through an extensive body of research. More than 30 peer-reviewed clinical studies conducted on over 800 patients demonstrate consistent and reliable results, contributing to high satisfaction rates among users. The Tixel devices carry FDA clearance, validating their safety and effectiveness within the regulatory framework.
Dr. Karen Herman, a dermatologist at Rejuvené MD, affirms that Tixel plays an integral role in her practice: "Our team and patients trust it. It's safe year-round for every skin type and delivers visible results without needles or lasers — giving patients comfort, confidence, and natural-looking outcomes."
In addition to its commitment to safety, Novoxel's unique technology represents the forefront of the next-generation energy-based devices designed for skin treatment. Operating since 2011, Novoxel has established itself as a leader in Thermo-Mechanical Action technology, which delivers pure thermal energy to the skin without invasive procedures.
With established markets in the USA, Canada, Europe, and beyond, Tixel is set to redefine how non-invasive treatments are approached, emphasizing minimal downtime while providing significant clinical outcomes in skin rejuvenation and other applications worldwide. For those seeking a notable advance in dermatological technology, Tixel remains a trusted choice supported by substantial clinical validation and a deep commitment to patient safety.
For more detailed information regarding Tixel and the Thermo-Mechanical Action technology, visit www.novoxel.com or contact [email protected].
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.